期刊文献+

抗HIV先导物DAAN-4048在大鼠肝微粒体的代谢产物 被引量:1

Metabolite profiling of anti-HIV lead compound DAAN-4048 in rat liver microsomes
下载PDF
导出
摘要 目的应用超高效液相色谱-四极杆飞行时间质谱联用技术(UPLC-QTOF-MS/MS)并辅以代谢数据采集和处理软件,快速筛查和鉴定了新型非核苷类逆转录酶抑制剂的先导物二芳烃取代苯胺类化合物(DAAN)-4048在大鼠肝微粒体的代谢产物,并分析结构中的代谢软点。方法应用质量亏损过滤技术在UPLC-QTOF-MS/MS上比较分析0 h与2 h孵育样品的数据,在大鼠肝微粒体孵育液中筛查得到了DAAN-4048的10个代谢产物。应用仪器的碰撞能量梯度功能(MSE)对部分产物进行MS2分析,获得代谢产物的碎片,推断碎裂途径及产物结构。结果结果表明,先导物在大鼠肝微粒体中发生广泛的代谢,Ⅰ相代谢反应以氧化(羟基化)为主,Ⅱ相代谢主要以谷胱甘肽结合反应为主。结论本文通过分析新型抗HIV先导物DAAN-4048的结构和代谢转化,发现易于发生代谢的位点和结构特征,为该类先导物结构优化和后续的临床前评价提供了科学指导。 Objective To perform the metabolite profiling of diarylaniline(DAAN)-4048,the lead compound from new classes of non-nucleoside reverse transcriptase inhibitors(NNRTI),by using an ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry(LC-QTOF-MS / MS),with the assistance of a metabolite data processing software.Methods By applying the mass defect filter(MDF) technique,the data acquired from the 0 h-incubate and the 2 h-incubate were compared and analyzed with the software.A total of 10 metabolites were found for DAAN-4048 in the 2 h-incubate.The MS2 spectra for some metabolites were obtained using the MSE technique to get fragment ions for structural elucidation.Results The results indicated the major metabolic pathways.The compound could undergo extensive metabolism in rat liver microsomes.The major phase Ⅰ reactions were oxidation / hydroxylation.The major phase Ⅱ reactions were S-glutathione conjugation.Conclusion The structure-metabolic pathway relationship was analyzed to reveal metabolic soft spots and the structure characterizations of the compound.This may provide scientific directions for lead structural optimization,as well as for further preclinical evaluation of the new chemical entities.
出处 《国际药学研究杂志》 CAS CSCD 2013年第4期491-496,共6页 Journal of International Pharmaceutical Research
基金 国家自然科学基金重点项目(30930106) 国家"重大新药创制"科技重大专项资助项目(2008ZXJ09006-001)
关键词 非核苷类逆转录酶抑制剂 二芳烃取代苯胺类化合物 大鼠肝微粒体 代谢产物 超高效液相色谱-四极杆飞行时间质谱 non-nucleoside reverse transcriptase inhibitors diarylaniline rat liver microsome metabolites UPLC-QTOFMS / MS
  • 相关文献

参考文献14

  • 1张红霞,黄荣清,杨建云,肖炳坤.艾滋病治疗药物的研究进展[J].科学技术与工程,2009,9(23):7081-7087. 被引量:11
  • 2朱翠云.抗艾滋病毒药物及治疗方案[J].上海医药,2011,32(11):531-534. 被引量:5
  • 3Domaoal RA, Demeter LM. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleo- side reverse transcriptase inhibitors[ J]. Ira J Biochem Cell Biol, 2004, 36(9) :1735-1751. 被引量:1
  • 4Pauwels R. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections [J]. C~rr Opin Pharmacol, 2004, 4(5) :437-446. 被引量:1
  • 5张兴权.抗艾滋病毒化学治疗药物的最新进展[J].药学学报,2010,45(2):194-204. 被引量:14
  • 6Tian X, Qin B, Wu Z, et al. Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors[J]. J Med Chem, 2010, 53 : 8287 -8297. 被引量:1
  • 7Tian X, Qin B, Lu H, et al. Discovery of diarylpyridine deriva- tives as novel non-nucleoside HIV-1 reverse transcriptase inhibi- tors[J]. Bioorg Med Chem Lett, 2009, 19(18) :5482-5485. 被引量:1
  • 8Qin, B, Jiang X, Lu H, et al. Diarylaniline derivatives as a dis- tinct class of HIV-1 non-nucleoside reverse transcriptase inhibi- torsi J]. J Med Chem, 2010, 53 (13) :4906-4916. 被引量:1
  • 9Zhang DL, Zhu MS, Humphreys WG. Drug Metabolism in Drug Design and Development: Basic Concepts and Practice. [ M ] translated by Zhong DF, Li H,. Beijing: People's Military Medi- cal Press, 201l: 167, 221-227. 被引量:1
  • 10王瑞,陈佳,秦炳杰,谢剑炜,李桦,谢蓝.两类抗HIV先导物的大鼠肝微粒体代谢产物筛查[J].药学学报,2012,47(12):1671-1677. 被引量:3

二级参考文献89

共引文献28

同被引文献15

  • 1Domaoal RA, Demeter LM. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors [ J ]. Int J Biochem Cell Bio1,2004, 36(9) :1735 - 1751. 被引量:1
  • 2Pauwels R. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections [ J ]. Curt Opin Pharmacol,2004,4 ( 5 ) :437 - 446. 被引量:1
  • 3Tian X, Qin B, Wu Z, et al. Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors [ J ]. J Med Chem, 2010,53 ( 2 ) : 8287 - 8297. 被引量:1
  • 4Tian X, Qin B, Lu H, et al. Discovery of diarylpyridine derivatives as novel non-nueleoside HIV-I reverse transcriptase inhibitors [ J ]. Bioorg Med Chem Lett,2009,19 ( 18 ) :5482 - 5485. 被引量:1
  • 5Qin B, Jiang X, Lu H, et al. Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors[ J]. J Med Chem,2010,53 ( 13 ) ,4906 - 4916. 被引量:1
  • 6Zhang DL, Zhu MS, Humphreys WG. Drug Metabolism in Drug De- sign and Development : Basic Concepts and Practice [ M ]. Beijing : People s Military Medical Press, 2011 : 167 ; 221 - 227. 被引量:1
  • 7US Food and Drug Administration. Pharmacology review (s) of etravirine [ EB/OL]. ( 2008-01-15 ) [ 2013-07-03 ] http ://www. accessdata, fda. gov/drugsatfda _ docs/nda/2008/022187s000 _ PharmR_P1. pdf. 被引量:1
  • 8Yanakakis LJ, Bumpus NN. Biotransformation of the antiretroviral drug etravirine : metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-depend- ent metabolism [ J ]. Drug Metab Dispos, 2012,40 ( 4 ) : 803 - 814. 被引量:1
  • 9Ripamonti D, Maqqiolo F. Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection[ J]. Curr Opin Investig Drugs, 2008,9 ( 8 ) : 899 - 912. 被引量:1
  • 10Anderson MS,Kakuda TN,Hanley W, et al. Minimal Pharmaco- kinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects [ J ]. Antimi- crob Agents Chemother,2008, 52 (12) :4228 - 4232. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部